We are live on ! Find out more
FCM

Fourpath Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 29.98%
This Fund
S&P 500
This Quarter Est. Return
+6.83%
1 Year Est. Return
+29.98%
3 Year Est. Return
+72.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$144M
AUM Growth
-$2.97M
Cap. Flow
-$10.8M
Cap. Flow %
-7.46%
Top 10 Hldgs %
48.25%
Holding
148
New
12
Increased
38
Reduced
78
Closed
8

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$530K
2
FJUL icon
FT Vest US Equity Buffer ETF July
FJUL
+$508K
3
GILD icon
Gilead Sciences
GILD
+$351K
4
TGT icon
Target
TGT
+$267K
5
LLY icon
Eli Lilly
LLY
+$238K

Top Sells

Rank Stock Value
1
RWM icon
ProShares Short Russell2000
RWM
+$3.92M
2
SJB icon
ProShares Short High Yield
SJB
+$2.41M
3
SH icon
ProShares Short S&P500
SH
+$2.23M
4
GDX icon
VanEck Gold Miners ETF
GDX
+$1.35M
5
MDT icon
Medtronic
MDT
+$565K

Sector Composition

Rank Sector Weight
1 Energy 16.92%
2 Technology 8.48%
3 Financials 6.92%
4 Healthcare 6.43%
5 Consumer Staples 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVDA icon
26
NVIDIA
NVDA
$4.91T
$1.1M 0.76%
12,200
-520
-4% -$37.7K
RIO icon
27
Rio Tinto
RIO
$147B
$1.08M 0.75%
16,881
+1
+0% +$67
NGG icon
28
National Grid
NGG
$83.6B
$1M 0.7%
15,600
-1,032
-6% -$65.3K
SPY icon
29
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$975K 0.68%
1,865
+2
+0.1% +$996
LYB icon
30
LyondellBasell Industries
LYB
$19.1B
$968K 0.67%
9,460
-238
-2% -$23.2K
AMLP icon
31
Alerian MLP ETF
AMLP
$12.7B
$939K 0.65%
19,779
+98
+0.5% +$4.4K
AVGO icon
32
Broadcom
AVGO
$1.76T
$908K 0.63%
6,850
-1,480
-18% -$183K
D icon
33
Dominion Energy
D
$62.5B
$877K 0.61%
17,838
-391
-2% -$18.3K
BCE icon
34
BCE
BCE
$20.4B
$861K 0.6%
25,347
-402
-2% -$15.3K
UPS icon
35
United Parcel Service
UPS
$100B
$858K 0.6%
5,775
-92
-2% -$14K
PNC icon
36
PNC Financial Services
PNC
$101B
$823K 0.57%
5,090
-131
-3% -$19.7K
GILD icon
37
Gilead Sciences
GILD
$167B
$813K 0.56%
11,093
+4,563
+70% +$351K
USB icon
38
US Bancorp
USB
$98.4B
$801K 0.56%
17,912
-371
-2% -$15.7K
JNJ icon
39
Johnson & Johnson
JNJ
$609B
$789K 0.55%
4,990
+29
+0.6% +$4.62K
AMGN icon
40
Amgen
AMGN
$198B
$785K 0.54%
2,760
-201
-7% -$58.8K
OGE icon
41
OGE Energy
OGE
$10.1B
$772K 0.54%
22,506
– –
VRTX icon
42
Vertex Pharmaceuticals
VRTX
$123B
$765K 0.53%
1,830
-75
-4% -$31.7K
KMB icon
43
Kimberly-Clark
KMB
$36B
$753K 0.52%
5,818
-121
-2% -$14.9K
KO icon
44
Coca-Cola
KO
$351B
$745K 0.52%
12,184
-170
-1% -$10.2K
META icon
45
Meta Platforms (Facebook)
META
$1.64T
$728K 0.5%
1,499
+41
+3% +$18.3K
AEP icon
46
American Electric Power
AEP
$71.9B
$727K 0.5%
8,438
-201
-2% -$16.3K
HBAN icon
47
Huntington Bancshares
HBAN
$37B
$716K 0.5%
51,348
-1,113
-2% -$14.4K
TRP icon
48
TC Energy
TRP
$72.7B
$709K 0.49%
17,649
-331
-2% -$13.1K
PFE icon
49
Pfizer
PFE
$143B
$706K 0.49%
25,456
+2,838
+13% +$78.8K
ET icon
50
Energy Transfer Partners
ET
$69.9B
$682K 0.47%
43,336
+162
+0.4% +$2.36K
1
2
3 4 5

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
AWC
Abundance Wealth Counselors State College, Pennsylvania $697M AUM 23.83% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
CA
Cortland Associates St Louis, Missouri $697M AUM 4.23% 1-Year Est. Return
AIA
Allied Investment Advisors Billings, Montana $697M AUM 21.33% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return

Fourpath Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Fourpath Capital Management held 148 positions worth $144M, down 2% from $147M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Fourpath Capital Management withdrew a net $10.8M in Q1 2024, closing 8 positions and reducing 78 holdings. Its most notable exit was Medtronic, an estimated $565K position sold in full.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

Against the trend, Fourpath Capital Management opened a new position in Bristol-Myers Squibb worth $564K.

  • Fourpath Capital Management's largest Q1 2024 buy was Bristol-Myers Squibb: 10,407 shares worth $564K.
  • Fourpath Capital Management added most to Gilead Sciences in Q1 2024, an estimated $351K increase.
  • Fourpath Capital Management's biggest Q1 2024 reduction was ProShares Short Russell2000, cutting an estimated $3.92M.
  • Fourpath Capital Management fully exited Medtronic in Q1 2024, selling an estimated $565K.
  • Fourpath Capital Management's ten largest holdings make up 48% of its $144M portfolio in Q1 2024.
  • Fourpath Capital Management opened 12 new positions and closed 8 in Q1 2024.
  • Fourpath Capital Management's portfolio value fell 2% quarter-over-quarter to $144M.

Based on Fourpath Capital Management's 13F filing for Q1 2024, filed 7 May 2024.